+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Intrapericardial cisplatin for the management of patients with large malignant pericardial effusion



Intrapericardial cisplatin for the management of patients with large malignant pericardial effusion



Journal Of Cancer Research & Clinical Oncology. 120(7): 434-436



Nine patients (seven men and two women), median age 57 years (range 40-68 years), with large malignant pericardial effusion confirmed by cytological examination, were treated with direct intrapericardial administration of cisplatin. After insertion of a polyurethane catheter, fluid was drained and cisplatin (10 mg in 20 ml normal saline) was instilled over 5 min during 5 consecutive days (total cisplatin dose: 50 mg). If fluid reaccumulation occurred the courses were repeated every 3 weeks. All of the patients achieved a complete therapeutic response (no more fluid reaccumulation). The median time of response was 2.8 months (range 1-24 months). Mild nausea occurred in two patients, supraventricular arrythmia in one patient and infectious complications in one patient. Eight patients died because of disease progression without evidence of cardiac tamponade or stricture. Autopsy, performed in 7 cases, revealed neoplastic involvement of the pericardium in all of the patients, but pericardial effusion was seen in one patient only.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 008908237

Download citation: RISBibTeXText

PMID: 8188738

DOI: 10.1007/bf01240144


Related references

Intrapericardial cisplatin for the management of patients with large malignant pericardial effusion in the course of the lung cancer. Lung Cancer 16(2-3): 215-222, 1997

Intrapericardial cisplatin in malignant pericardial effusion. European Journal of Cancer 27(SUPPL 3): S57, 1991

Evaluation of intrapericardial cisplatin administration in cases with recurrent malignant pericardial effusion and cardiac tamponade. Supportive Care in Cancer 12(1): 53-57, 2003

Evaluation of intrapericardial cisplatin administration in cases of recurrent malignant pericardial effusion and cardiac tamponade. Pneumonologia i Alergologia Polska 64 Suppl 2: 180-186, 1996

Intrapericardial infusion of etoposide and cisplatin in treating malignant pericardial effusion of non-small cell lung cancer. Ai Zheng 25(4): 505-508, 2006

Intrapericardial ok 432 installation for the management of malignant pericardial effusion. Cancer 68(2): 259-263, 1991

Intrapericardial interferon in the management of malignant pericardial effusion. Chest 114(1): 330-331, 1998

Intrapericardial instillation of bleomycin in the management of malignant pericardial effusion. European Journal of Cancer & Clinical Oncology 25(10): 1505-1506, 1989

Intrapericardial instillation of cisplatin in a patient with a large malignant effusion. Cancer Drug Delivery 2(1): 49-52, 1985

Intrapericardial cisplatin combined with oral colchicine resulted in long term control of malignant pericardial effusion in the course of metastatic renal cancer. Advances in Respiratory Medicine: -, 2018

Intrapericardial instillation of OK-432 for the management of malignant pericardial effusion: report of three cases. Japanese Journal of Medicine 28(1): 62-66, 1989

Intrapericardial bleomycin for the management of cardiac tamponade secondary to malignant pericardial effusion. British Heart Journal 63(1): 61-62, 1990

Intrapericardial tetracycline for the management of cardiac tamponade secondary to malignant pericardial effusion. New England Journal of Medicine 299(20): 1113-1114, 1978

Intrapericardial mitomycin C for the management of malignant pericardial effusion secondary to gastric cancer: case report and review. ChemoTherapy 40(1): 57-60, 1994

Ultrasound guided pericardial drainage and intrapericardial instillation of mitomycin C for malignant pericardial effusion. Thorax 49(6): 594-595, 1994